University of Colorado Boulder 1002176187

mRNA Decapping Enzyme; Micrococcal Nuclease; RNase Inhibitor Murine

On August 14, 2025, the University of Colorado Boulder, a state government institution in Colorado, awarded a contract worth $453.90 to New England Biolabs Inc for specific molecular biology products, including mRNA Decapping Enzyme, Micrococcal Nuclease, and RNase Inhibitor Murine. The contract encompasses three line items with individual prices of $95.20, $73.95, and $284.75 respectively, totaling one unit each. The university's procurement was handled through a single purchase order, and the vendor will deliver the specified biological reagents. The award aligns with state procurement standards, and the university's hierarchy places it under Colorado's public higher education sector.

Description

mRNA Decapping Enzyme; Micrococcal Nuclease; RNase Inhibitor Murine